234 results about "Gram negative bacterium" patented technology

The invention relates to the technical field of antibacterial peptide application, in particular to an antibacterial peptide for inhibiting drug-resistant acinetobacter baumannii as well as a preparation method and application of the antibacterial peptide. The antibacterial peptide is cd77AHP-2, and the amino acid sequence of the antibacterial peptide is shown as SEQ ID NO.1. The antibacterial peptide cd77 obtained through artificial chemical synthesis is modified, distribution of cationic amino acid is optimized, and the antibacterial activity of the antibacterial peptide is remarkably improved. The antibacterial peptide cd77AHP-2 has a remarkable antibacterial effect on acinetobacter baumannii which are gram-negative bacteria and multi-drug resistant acinetobacter baumannii, and the antibacterial peptide cd77AHP-2 has a remarkable antibacterial effect on the acinetobacter baumannii which are gram-negative bacteria. The antibacterial peptide cd77AHP-2 provided by the invention has relatively low cytotoxicity to human bronchial epithelial cells, and has the potential of preparing a drug for resisting drug-resistant acinetobacter baumannii. The invention provides a novel functional polypeptide for the field of antibacterial peptides, and the novel functional polypeptide has important practical application value.

The invention belongs to the technical field of antibacterial peptides, and particularly relates to an antibacterial peptide and application thereof. The amino acid sequence of the antibacterial peptide is shown as SEQ ID NO: 1, the number of amino acids is small, the synthesis cost is low, the antibacterial peptide has high antibacterial activity on gram-negative bacteria and gram-positive bacteria, the minimum inhibitory concentration of the antibacterial peptide on acinetobacter baumannii, escherichia coli, pseudomonas aeruginosa and staphylococcus aureus is 4.68-37.5 mu g / mL, and the antibacterial peptide has the advantages of broad-spectrum antibacterial property, good stability and good application prospect. No obvious cytotoxicity and hemolysis effect exist; moreover, end-to-end amido bond cyclization is carried out, so that the antibacterial activity is further enhanced, the antibacterial effect on acinetobacter baumannii, escherichia coli, pseudomonas aeruginosa and staphylococcus aureus is enhanced by 2-4 times, and the minimum inhibitory concentration is reduced to 2.34-9.38 mu g / mL; after the end-to-end amido bonds are cyclized, the plasma stability and safety of the antibacterial peptide are further improved, and the cytotoxicity and hemolysis are reduced.

The invention belongs to the technical field of biological medicines, and relates to an antibacterial polypeptide, a composition and application thereof. The amino acid sequence of the antibacterial polypeptide is as shown in SEQ ID NO. 1: KWKIKWPVKWFKM-NH2. The invention also discloses a preparation method of the antibacterial polypeptide. Experiments show that the antibacterial polypeptide disclosed by the invention has broad-spectrum antibacterial activity on gram-positive bacteria and / or gram-negative bacteria, and also has low cytotoxicity and low hemolysis. The antibacterial polypeptide provided by the invention consists of 14 amino acids, is relatively short in peptide chain, small in molecular weight and easy to artificially synthesize, is a micromolecular polypeptide with extremely high application value, can be used for preparing a novel antibacterial agent, and has a wide application prospect.

The invention belongs to the technical field of biomedical materials, and discloses injectable heterogeneous cascade nano-enzyme antibacterial hydrogel as well as a preparation method and application thereof. The preparation method comprises the following steps: in a process of preparing cerium dioxide nano-enzyme by a reverse micelle method, introducing molybdenum disulfide nano-particles with a nano flower-shaped structure so as to deposit the cerium dioxide nano-enzyme on the surfaces of the molybdenum disulfide nano-particles in situ to obtain nano-composite particles; through electrostatic interaction, glucose oxidase is loaded on the surfaces of the nano composite particles to form a heterogeneous cascade nano enzyme material; the preparation method comprises the following steps: uniformly mixing sodium alginate and hyaluronic acid in water, and sequentially adding an NO donor, a heterogeneous cascade nano-enzyme material and a cross-linking agent to obtain the injectable heterogeneous cascade nano-enzyme antibacterial hydrogel. The preparation method is simple, and the injectable heterogeneous cascade nano-enzyme antibacterial hydrogel has a strong antibacterial effect and can be used for preparing the antibacterial hydrogel. Particularly, the compound has a remarkable killing effect on gram-negative bacteria and gram-positive bacteria.

The invention discloses an antibacterial peptide sequence for inhibiting gram-negative bacteria and application of the antibacterial peptide sequence. A plurality of antibacterial peptides are designed for gram-negative bacteria, and antibacterial test results show that the amino acid sequence shown in SEQ ID No.4 has an exact inhibition effect on two gram-negative bacteria and also has a certain inhibition effect on staphylococcus aureus; in addition, the amino acid sequence as shown in SEQ ID No.2 has an exact inhibition effect on gram-positive bacterium micrococcus luteus and fungus candida albicans, and the inhibition rates are 99.32% and 93.42% respectively. The invention further provides application of the antibacterial peptide in preparation of drugs for resisting bacterial or fungal infection.

The invention relates to application of ten antibacterial peptides in the antimicrobial field. The ten antibacterial peptides have strong antibacterial activity on multi-drug-resistant bacteria, including but not limited to gram-negative bacteria such as escherichia coli, pseudomonas aeruginosa, acinetobacter baumannii, klebsiella pneumoniae and the like, and gram-positive bacteria such as staphylococcus aureus, enterococcus faecalis and the like. Activity research proves that any one of the ten antibacterial peptides has a remarkable effect of inhibiting, killing or preventing microbial infection. Due to the strong antibacterial property of any antibacterial peptide, the antibacterial peptide has wide application potential in the aspects of preparing antibacterial drugs, preservatives, antibacterial coatings, antibacterial fibers, antibacterial packaging materials and the like. Due to the unique property of the antibacterial peptide in the aspect of antibacterial performance, a new direction is provided for the development of efficient and reliable antibacterial agents and antibacterial technologies and products in multiple fields.

The invention discloses a lactobacillus rhamnosus capable of improving joint inflammation and promoting bone health, a metagen and application of the lactobacillus rhamnosus, the lactobacillus rhamnosus is lactobacillus rhamnosus BN02, the lactobacillus rhamnosus is preserved in China General Microbiological Culture Collection Center on November 27, 2023, and the preservation number is CGMCC No.29133. The lactobacillus rhamnosus can be used for improving joint inflammation and promoting bone health. The lactobacillus rhamnosus BN02 can reduce the number of gram-negative bacteria in intestinal tracts of arthritis patients, increase the synthesis amount of bone collagen, and is beneficial to promoting absorption of vitamin C by the intestinal tracts, improving joint inflammation and promoting bone health.

The invention discloses a preparation method and application of a cow milk antibacterial peptide with wide inhibitory activity on gram-positive bacteria and gram-negative bacteria by a fermentation method, the cow milk antibacterial peptide is prepared by taking milk protein as a raw material through a microbial fermentation method and a multi-stage membrane separation and purification process, the yield of the cow milk antibacterial peptide prepared by the method can reach 18-30%, and the yield of the cow milk antibacterial peptide prepared by the method can reach 18-30%. And the peptide content in the product is 60-85%. The cow milk antibacterial peptide prepared by the preparation method disclosed by the invention has inhibitory activity on gram-positive bacteria and gram-negative bacteria. The prepared cow milk antibacterial peptide can be used for preparing drugs and / or health care products, food and skin care products for preventing and / or reducing infectious diseases caused by escherichia coli, staphylococcus aureus, pseudomonas aeruginosa, porphyromonas gingivalis and streptococcus mutans, can also be used as a food preservative, an oral bacteriostatic agent, a preservative and the like, and has a good application prospect.

The invention provides a beta-lactam inhibitor and cephalosporin medicine composition as well as a preparation method and application thereof, and belongs to the technical field of pharmacy. The composition disclosed by the invention is prepared from the following components in parts by weight: 5 to 90 parts of beta-lactamase inhibitor and 0.01 to 50 parts of cephalosporin medicine. The antibacterial activity of the composition on gram-positive bacteria and gram-negative bacteria is remarkably improved, the antibacterial spectrum is expanded, and meanwhile the clinical application range is widened.

An antibacterial polymer having a molecular weight above a certain level, which is highly miscible with other polymers compared to a monomolecular type antibacterial agent and can be added during the melt extrusion process. Further the antibacterial polymer has the advantage of exhibiting excellent antibacterial properties against Gram-negative bacteria and does not elute over time.

The invention provides an antibacterial peptide derived from zebra fish, the amino acid sequence of the antibacterial peptide is SEQ ID NO: 1, and the sequence of coding nucleotide of the antibacterial peptide is SEQ ID NO: 2. The antibacterial peptide provided by the invention can be used for preparing products for preventing, treating and resisting bacteria. The zebrafish antibacterial peptide mP60-81 disclosed by the invention has a remarkable antibacterial effect on gram-positive bacteria and gram-negative bacteria, is wide in antibacterial spectrum, has great use value, and has better application in the aspect of developing and preparing antibacterial agents. The antibacterial peptide is derived from zebra fish, can be applied to aquaculture as a feed additive, and can also be developed into an antibacterial agent, an antibacterial drug and the like, so that the antibacterial peptide has a wide application prospect.

The present invention discloses a strong, non-toxic, antibacterial and antiviral nano-functional material and a preparation method thereof. The nano-functional material is green, non-toxic and harmless, and its antibacterial and antiviral effect can reach more than 99%. The new nano-material innovatively uses the natural antibacterial agent meta-dichlorostyrene meta-dichloroacetophenone as the main body of the material to exert its antibacterial and antiviral effects. This makes the new nano-material not only have extremely strong antibacterial and antiviral effects, but also as a natural antibacterial agent, when it is used as a textile material, it can be non-toxic and harmless to the human body, green and healthy. It has a better inhibitory effect on both Gram-negative and Gram-positive bacteria than nano-copper oxide and meta-dichlorophenylethanol and meta-dichloroacetophenone. The present invention also provides a preparation method for the nano-functional material, which includes chemical reaction processes such as boron hydrolysis reaction, catalytic oxidation reaction, electrocarboxylation reaction, and esterification reaction.

The invention discloses a bacteriophage lyase and application thereof, and particularly relates to a bacteriophage lyase with an amino acid sequence as shown in SEQ INNO.2. The bacteriophage lyase can inhibit the growth of escherichia coli, staphylococcus and salmonella, can be used as an antibacterial substance in splitting gram-negative bacteria and can be used for preparing drugs for resisting gram-negative bacteria. The lyase can be used independently or compounded with other substances, the use concentration of antibiotics can be reduced by combining the lyase with the antibiotics, toxic and side effects (such as renal toxicity of polymyxin) of drugs are reduced, and meanwhile, generation of bacterial drug resistance is delayed. After the lyase and the chitosan are combined for use, remarkable antibacterial activity is generated, the antibacterial effect can be achieved without pre-treatment on bacteria, and the practicability is improved.

The invention belongs to the field of genetic engineering and biological treatment, and provides an eukaryotic expression vector, gram-negative bacteria containing the eukaryotic expression vector and application of the eukaryotic expression vector in preparation of tumor drugs. By selecting and combining a phage-derived promoter, a specific phage RNA polymerase gene, a membrane rupture protein gene and an eukaryotic expression drug protein gene, an eukaryotic expression vector is divided into three modules: (1) a phage-derived RNA polymerase gene transcription module; (2) a membrane rupture protein gene expression module; and (3) a eukaryotic drug protein gene expression module. Through organic combination of the three modules, the eukaryotic drug delivery system is constructed, and the system and method for stably and efficiently performing eukaryotic drug protein expression, drug delivery and drug killing are realized.

The invention provides an antibacterial peptide and application thereof in resisting bacteria and / or enhancing the disease resistance of plants. Specifically, on one hand, the invention provides two antibacterial peptides which are novel functional antibacterial peptides ZJUAMP3 and ZJUAMP4, sequences of the novel functional antibacterial peptides ZJUAMP3 and ZJUAMP4 are respectively shown as SEQ ID NO: 1 and SEQ ID NO: 2, and the antibacterial peptides ZJUAMP3 and ZJUAMP4 both have broad-spectrum antibacterial activity, have good antibacterial activity on bacteria such as gram-negative bacteria, gram-positive bacteria and fungi, and are suitable for scenes needing sterilization or fungus and bacterium growth inhibition. Besides, the ZJUAMP4 can activate an MAPK signal channel in a plant body and induce the plant to generate systematic disease resistance, and is suitable for the fields of crop disease prevention and control and plant protection. The antibacterial peptide is simple in structure and easy to synthesize.

The invention discloses defensive pseudomonas L4BXN with phosphate solubilizing capacity and application thereof, and belongs to the technical field of phosphate solubilizing bacteria. The pseudomonas with the phosphate-solubilizing capacity is a new strain, namely gram-negative bacteria, the optimum growth temperature is 25-30 DEG C, inorganic phosphorus can be decomposed, and the phosphate-solubilizing amount in 7 days is 169 mg.L <-1 >; when the pseudomonas with the phosphate solubilizing capacity is applied to soil, accumulation of biomass of the overground part and the underground part of arabidopsis thaliana can be remarkably promoted, and particularly increase of root length, root area, root volume, branch number, dry weight and fresh weight is promoted; the provided pseudomonas with the phosphate solubilizing capacity has huge application prospects in plant growth promotion, soil improvement and remediation, and has important significance in promotion of agricultural health and sustainability and improvement of the effective utilization rate of phosphorus in soil.

The invention discloses an application of an SIRT1 gene in regulating and controlling innate immune response of poultry. The application of the SIRT1 gene or protein in regulating the innate immune pathway of poultry is disclosed for the first time, and powerful scientific basis and tools are provided for prevention, control and treatment of gram-negative bacteria such as salmonella. The inhibitor of the targeted gene SIRT1 provided by the invention can significantly improve the resistance of chicken macrophages to salmonella, and provides a scientific means for scientific research and industrial application related to prevention and control of gram-negative bacteria such as salmonella.

The invention provides a preserving fluid for preserving host and gram-negative bacterium nucleic acid in an excrement sample, and particularly discloses an excrement preserving fluid capable of effectively splitting and releasing host intestinal cast-off cell DNA and gram-negative bacterium DNA and splitting gram-positive bacterium DNA less. Therefore, the Gram-negative pathogenic bacteria can be used for screening various Gram-negative pathogenic bacteria and can also be used for primary screening and general survey of diseases such as colorectal cancer of a host, and interference of nucleic acid of Gram-positive bacteria on detection is remarkably reduced.

The invention discloses an anti-infection application of C-reactive protein. The invention provides an application of C-reactive protein in preparation of a product for preventing and / or treating infection. The invention creatively finds that the C-reactive protein can be widely combined with polysaccharide capsular structures on the surfaces of various gram-positive bacteria and gram-negative bacteria in a blood circulation system, and the bacteria marked by the C-reactive protein are quickly transferred from blood to the surface of liver macrophages-Kukhou cells, so that the bacteria are quickly phagocytized and cleared in the liver; therefore, pathogens invading the blood can be effectively removed. The C-reactive protein has a broad-spectrum antibacterial function of identifying and eliminating a plurality of gram-positive and gram-negative pathogenic bacteria. In a C-reactive protein deficient individual, the recombinant C-reactive protein is injected, so that the C-reactive protein can obtain antibacterial immune protection.

Disclosed are compositions comprising a Gram negative needle tip protein and a translocator protein and methods of their use.

The invention relates to an antibacterial peptide LK-KJT-B01 for gram-negative bacterium infection and a preparation method and application thereof.The antibacterial peptide LK-KJT-B01 can be extracted from bacillus laterosporus, has the advantages of being broad in spectrum, safe, free of toxicity and the like, has a very strong bactericidal effect on gram-negative bacterium infection, and can be used for preparing antibacterial peptide LK-KJT-B01 for gram-negative bacterium infection. Particularly, the sensitivity to carbapenem-resistant gram-negative bacteria is high, and the application prospect is very wide.

The invention discloses a preparation method and application of sodium gallate-polyphenol chitosan antibacterial hydrogel, firstly, gallic acid and sodium acetate are used as raw materials, a high-purity sodium gallate complex 5-carboxyl-2, 3-sodium dihydroxyphenolate is prepared at normal temperature and normal pressure, then a polyphenol compound and chitosan are cross-linked through Schiff base reaction, and the sodium gallate-polyphenol chitosan antibacterial hydrogel is obtained. And finally, carrying out rotary evaporation treatment, so that the sodium gallate is loaded in the polyphenol chitosan hydrogel system to obtain the antibacterial hydrogel. Sodium gallate is used as a functional component, uniform loading of sodium gallate in a polyphenol chitosan hydrogel system is realized through dual effects of physical adsorption and chemical bonding, the loading mechanism can effectively avoid aggregation and burst release of sodium gallate, stable release of antibacterial components is ensured, and the antibacterial property of the hydrogel is improved. The slow release time of the antibacterial hydrogel under the conditions that the pH values are 5.5 and 7.2 respectively exceeds 24 hours; and the antibacterial hydrogel has an inhibition effect on both gram-positive bacteria and gram-negative bacteria.

The invention discloses a membrane-rupturing antibacterial peptide and application thereof. On the basis of an artificial intelligence screening method, a membrane-rupturing antibacterial peptide KLAKLLKLLLWAQNELDQKK is identified from a proteome of toads, the membrane-rupturing antibacterial peptide has three positive charges, and 50% of amino acid is hydrophobic amino acid. Through experimental tests, the antibacterial peptide can inhibit the growth of 10 different strains including gram negative strains and gram positive strains; meanwhile, the semi-maximum hemolysis concentration and the semi-maximum cytotoxicity concentration of the antibacterial peptide are both greater than 128 mu g / mL, and the antibacterial peptide has good biological safety. The antibacterial peptide plays an antibacterial role by destroying cell membranes, has the characteristic that the drug resistance of bacteria is not easily caused, and is an ideal development object of antibacterial drugs and antibacterial products such as disinfectants, detergents and feed additives.

The present invention relates to a pharmaceutical composition for use against Gram-negative bacteria comprising at least one efflux pump inhibitor and at least one antibiotic. The invention also relates to the use of said pharmaceutical composition for resisting microorganisms, in particular bacteria, in particular gram-negative bacteria.

The present application relates to a compound as shown in the following formula (1) or a pharmaceutically acceptable salt thereof, wherein R is C1-6 alkyl. The present application also relates to the use of the compound or the pharmaceutically acceptable salt thereof for preparing a drug for resisting gram-negative bacteria, and a method for preparing the compound or the pharmaceutically acceptable salt thereof.

The present invention is predicated on success at producing a substance that results from removing LPS from a plant fermentation extract and the discovery that said substance demonstrates a biological activity that cannot be explained by conventional scientific common knowledge. The present invention is a method for obtaining an LPS-removed plant fermentation extract, an LPS-removed plant fermentation extract that is obtained using said method, and a formulation in which said LPS-removed plant fermentation extract has been compounded, said method being characterized by comprising a step in which LPS is removed from a plant fermentation extract that is obtained by fermenting a material derived from an edible plant, using a facultative anaerobic gram-negative bacterium that is exclusively symbiotic with the plant, and simultaneously cultivating said facultative anaerobic gram-negative bacterium.

The present application relates to the technical field of polysaccharide modification, and specifically discloses amino acid modified astragalus polysaccharide, a preparation method thereof and antibacterial application. The present application uses astragalus polysaccharide, formaldehyde and specific amino acids as raw materials, and prepares amino acid grafted modified astragalus polysaccharide through a Mannich reaction. The amino acid grafting site only occurs on the fifth carbon of the sugar ring. Not only does this retain the amino and carboxyl groups of the amino acid, so that the biological activity of the amino acid is retained, but also the active carboxyl group of the astragalus polysaccharide can be retained, so that the antibacterial property of the synthesized amino acid modified astragalus polysaccharide is significantly improved, and broad-spectrum antibacterial property can be achieved. The amino acid modified astragalus polysaccharide has excellent antibacterial activity on gram-positive bacteria and gram-negative bacteria, is a green new type of efficient antibacterial material, and is expected to become a substitute for antibiotics. The amino acid modified astragalus polysaccharide has important significance for solving the problems of increasing bacterial drug resistance and environmental accumulation caused by antibiotics, and has good application prospect.

The present invention belongs to the field of microbiology, and particularly relates to membrane vesicles (MVs) isolated from bacteria, and an isolation and preparation system and method for the membrane vesicles, and applications of the membrane vesicles. The bacteria of the present invention comprise Gram-positive bacteria and Gram-negative bacteria. The invention uses ionizing irradiation to irradiate bacteria, and isolates and purifies the produced membrane vesicles. The membrane vesicles prepared can be used as a vaccine, a vaccine adjuvant and / or a pharmaceutical carrier. In addition, the present invention provides a biological composition comprising the membrane vesicles and inactivated bacteria. In addition, the present invention also provides a preparation system, and isolation and purification system for bacterial membrane vesicles and the corresponding method. The membrane vesicles obtained by using the system and method have high yield, high purity and easy to be industrialized.

The application discloses a kind of implant and its preparation method and application, the implant includes material body, metal oxide layer and mixed crystal layer, the mixed crystal layer is located the surface of the metal oxide layer;The metal oxide layer includes metal oxide nanorod array;The metal oxide is selected from zinc oxide, silver oxide or its combination;The mixed crystal layer includes CaP crystal and metal oxide crystal.The implant of the application is sterilized by the bacteriostatic metal ion generated by physical puncture and degradation of metal oxide nanorod, has good antibacterial effect to gram-positive bacteria and gram-negative bacteria, prevents infection;It can also relieve post-implantation inflammatory response, reduce immune response under post-implantation infection, shorten wound healing time.In addition, due to the coating effect of mixed crystal layer on metal oxide layer, the bacteriostatic metal ion is slowly released, the release time is long, and long-lasting antibacterial effect can be achieved, and post-implantation inflammatory response can be reduced.

The present invention discloses an antimicrobial peptide PmAMP12 from pearl columnar algae, and its amino acid sequence is shown in SEQ ID NO: 2. The present invention also discloses its application in antibacterial. Expressing PmAMP12 on the cell surface of Agrobacterium tumefaciens can destroy the integrity of Agrobacterium tumefaciens cells; PmAMP12 exhibits inhibitory activity against a variety of Gram-negative bacteria, Gram-positive bacteria and fungi, and studies have also found that PmAMP12 can directly destroy the integrity of cells and cause changes inside cells. The antimicrobial peptide PmAMP12 of the present invention provides a new and excellent biological resource for the development of green biological pesticides, and has great application potential in agricultural production.